Table of Contents
1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Supply Chain Analysis
6 Asia Pacific Orthopedic Biomaterial Market, by Type of Material
6.1 Metal
6.1.1 Stainless Steel
6.1.2 Titanium Alloy
6.1.3 Cobalt Alloy
6.1.4 Others
6.2 Non- Metal
6.2.1 Ceramic
6.2.1.1 Alumina
6.2.1.2 Calcium Phosphate
6.2.1.3 Zirconium Dioxide
6.2.1.4 Carbon
6.2.1.5 Other
6.2.2 Polymeric
6.2.2.1 Polymethylmethacrylate (Pmma)
6.2.2.2 Polyethylene
6.2.2.3 Silicone
6.2.2.4 Polyester
6.2.2.5 Other
6.2.3 Natural Biomaterials
6.2.3.1 Collagen
6.2.3.2 Chitin & Chitosan
6.2.3.3 Other
6.3 Others.
7. Asia Pacific Orthopedic Biomaterial Market, by Application
7.1 Joint Replacement
7.1.1 Hip Replacement
7.1.2 Knee Replacement
7.1.3 Shoulder and Elbow Replacement
7.1.4 Other
7.2 Fracture Fixation Devices
7.2.1 Screws
7.2.2 Plates for Bones
7.2.3 Rods
7.2.4 Other
7.3 Tissue Fixation
7.3.1 Interference Screws
7.3.2 Suture Anchors
7.3.3 Others
7.4 Spine Implants
7.5 Viscosupplementation
7.6 Other
8 Asia Pacific Orthopedic Biomaterial Market, by Regions
8.1 Introduction
8.1.1 Japan
8.1.2 China
8.1.3 India
8.1.4 Australia
8.1.5 Republic of Korea
8.1.6 Rest of Asia-Pacific
9. Competitive Landscape
9.1 Major Strategies Adopted By Market Players
9.1.1 Strategic Partnership
9.1.2 Merger & Acquisition
10 Company Profile
10.1 Kyocera Corporation
10.1.1 Overview
10.1.2 Product Overview
10.1.3 Financials
10.1.4 Key Developments
10.2 Materion Corporation
10.2.1 Overview
10.2.2 Product Overview
10.2.3 Financials
10.2.4 Key Developments
10.3 Kanghui Holdings
10.3.1 Overview
10.3.2 Product Overview
10.3.3 Financials
10.3.4 Key Development
10.4 Royal Dsm
10.4.1 Overview
10.4.2 Product Overview
10.4.3 Financials
10.4.4 Key Developments
10.5 Ceramtec
10.5.1 Overview
10.5.2 Product Overview
10.5.3 Financials
10.5.4 Key Developments
10.6 Johnson & Johnson
10.6.1 Overview
10.6.2 Product Overview
10.6.3 Financials
10.6.4 Key Developments
10.7 Tianjin Walkman Biomaterial Co.
10.7.1 Overview
10.7.2 Product Overview
10.7.3 Financials
10.7.4 Key Developments
10.8 Cam Bioceramics B.V.
10.8.1 Overview
10.8.2 Product Overview
10.8.3 Financials
10.8.4 Key Developments
10.9 Covestro
10.9.1 Overview
10.9.2 Product Overview
10.9.3 Financials
10.9.4 Key Developments
10.10 Others
11 Conclusion
11.1 Key Findings
11.1.1 From CEO’s Viewpoint
11.1.2 Unmet Needs of the Market
11.2 Key Companies to Watch
11.3 Prediction of Orthopedic Biomaterials Industry
12 Appendix